Consensus expectations for UnitedHealth Group's Q1 2026 earnings include an EPS of $6.48 on revenue of $109.45 billion, with the stock currently trading at $324.63 against an average analyst target of $401.90.
The primary focus for investors is the Medical Care Ratio (MCR), specifically looking for stabilization in medical utilization trends within the Medicare Advantage segment.
Shares have faced pressure recently due to rising medical costs and tighter federal reimbursement rules, resulting in a year-to-date decline. Analysts are watching for updates on cost-containment strategies and Optum’s performance to gauge the potential for a margin recovery.